#MantleCellLymphoma consists of a spectrum of clinical subtypes.¹ However, diagnosing cases of cyclin D1-negative #MCL can be challenging.¹,² How do you approach the diagnosis and management of cyclin D1-negative MCL in your practice? #ASH23
Loxo@Lilly International’s Post
More Relevant Posts
-
Listen to a discussion about "Outcomes After Minimally Invasive Surfactant Therapy." https://ja.ma/3t1zHkc https://ja.ma/3t1zHkc
To view or add a comment, sign in
-
Metaphase: Metaphase is a stage in cell division, specifically in mitosis and meiosis, where the chromosomes align at the cell's equator. During metaphase, the chromosomes become attached to the spindle fibers and are arranged in a single plane called the metaphase plate. This alignment ensures that each daughter cell receives the correct number of chromosomes during cell division. Don’t hesitate: Our team of Exam Counsellors is here to assist you +44 7307 237595 Sincerely & our dedication is to serve you, Med Recalls #MRCSstudents #MRCSExam #MedicalEducation #patientcare #medicalawareness #Medicine#HealthcareEducation #Doctors #medicalprofessionals #RCOG #MRCOG1 #MRCOG2 #MRCOG3 #oetpreparation #plabexam #healthcareprofessionals #medacademy #MRCP #MRCS #MRCPI #EBCOG #FCPS #MCPS #MRCPCH #FCPS #PLABWebinar #KeepPushing #NeverBackDown #MedicalDreams #medrecalls
To view or add a comment, sign in
-
-
Zephyr Valve results are backed by consistent clinical findings across four randomized controlled trials. See the data on this minimally invasive treatment for patients suffering from severe #COPD/#emphysema. Read the clinical findings here: https://bit.ly/461QvWK #MedicalInnovation #Pulmonology #MedicalDevices #medtech #lung #pulmonary #respiratory
To view or add a comment, sign in
-
-
This detailed slide deck of the latest study by Afif, et al. shows the final efficacy and safety results of the UNIFI LTE study through 4 years. They found that long-term subcutaneous therapy with ustekinumab in patients who responded to intravenous ustekinumab was safe and effective at maintaining symptomatic remission. You can find the full paper summary on the IMID Forum completely free along with the latest updates in #Crohn’sDisease https://ow.ly/UqCk50SiKsq
To view or add a comment, sign in
-
-
#NuwellisNews: A newly published case series demonstrates the potential value of #Aquadex when treating patients with fluid overload as a result of end-stage #LiverDisease: https://lnkd.in/giZUbDPj The study shows aquapheresis therapy could benefit these patients with a crucial need for fluid balance support when they don’t respond to #diuretics. Read the full release to learn more. 👆 #Aquapheresis #Ultrafiltration #MedTech #LiverHealth #FluidOverload
To view or add a comment, sign in
-
📢#PCRLV Simultaneous publication This study investigated the association of residual mitral regurgitation and mitral valve pressure gradient with clinical outcomes after transcatheter edge-to-edge repair in patients with atrial functional mitral regurgitation. Read results & conclusions. 👇@TETSUTANAKA5 #MedEd #CardioEd #MedicalEducation https://ow.ly/uZ8e50Q99Jb
To view or add a comment, sign in
-
-
How To Navigate IBS and Tempting Food Over the Holidays? With the holiday season now in full swing, tempting foods that could cause gastrointestinal distress are lurking everywhere: https://lnkd.in/gb9W4ssg NeurAxis, founded in 2012, is a medical technology company specializing in neuromodulation therapies for chronic conditions in both children and adults. Their IB-Stim therapy, utilizing Percutaneous Electrical Nerve Field Stimulation (PENFS) technology, has FDA clearance for pediatric functional abdominal pain associated with IBS and is undergoing clinical trials for various other conditions. Committed to evidence-based research, NeurAxis aims to enhance adoption by the clinical and scientific communities. The IB-Stim product offers superior efficacy and safety compared to standard pharmacotherapy, and NeurAxis is actively expanding insurance coverage. #neuraxis #nrxs #nyse
To view or add a comment, sign in
-
-
Clinical & Sales Lead | Strong clinical, sales & marketing expertise | Sports Scientist | Driven, resourceful problem-solver in a fast-paced & constantly evolving scale-up environment
Transcatheter edge-to-edge repair (TEER) is a standard care procedure for many years now. Still, the prognostic benefits of TEER remain unclear in patients with atrial functional mitral regurgitation (AFMR). This recent investigation aimed for clinical outcomes in TEER for patients with AFMR Check out the full paper here: #teer #edgetoedge #afmr #mitralvalverepair
Outcomes of transcatheter edge-to-edge repair for atrial functional mitral regurgitation
eurointervention.pcronline.com
To view or add a comment, sign in
-
How To Navigate IBS and Tempting Food Over the Holidays? With the holiday season now in full swing, tempting foods that could cause gastrointestinal distress are lurking everywhere: https://lnkd.in/gW_zAYyF NeurAxis, founded in 2012, is a medical technology company specializing in neuromodulation therapies for chronic conditions in both children and adults. Their IB-Stim therapy, utilizing Percutaneous Electrical Nerve Field Stimulation (PENFS) technology, has FDA clearance for pediatric functional abdominal pain associated with IBS and is undergoing clinical trials for various other conditions. Committed to evidence-based research, NeurAxis aims to enhance adoption by the clinical and scientific communities. The IB-Stim product offers superior efficacy and safety compared to standard pharmacotherapy, and NeurAxis is actively expanding insurance coverage. #neuraxis #nrxs #nyse
To view or add a comment, sign in
-
-
Avacopan is safe and efficacious for patients with ANCA-associated vasculitis (AAV) receiving background induction therapy with rituximab, according to research in @ARD_BMJ. https://brnw.ch/21wG7Ut
Data Confirm Role of Avacopan as Therapy to Sustain AAV Remission to 52 Weeks - Renal and Urology News
To view or add a comment, sign in